Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4885-4896

  Del Rio, Maria Luisa ^a   Jones, Nick D ^b   Buhler, Leo ^c   Norris, Paula ^d   Shintani, Yasushi ^e   Ware, Carl F ^d   Rodriguez Barbosa, Jose Ignacio ^a  

^a UNIVERSITY OF LEÓN   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d BURNHAM INSTITUTE   (United States)

^e Takeda Pharmaceutical   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERPESVIRUS ENTRY MEDIATOR; HERPESVIRUS ENTRY MEDIATOR ANTIBODY; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOIMMUNITY; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; DONOR LYMPHOCYTE INFUSION; FEMALE; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUPPRESSOR CELL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTE SUBSETS; CELL MOVEMENT; CHO CELLS; CRICETINAE; FEMALE; GRAFT VS HOST REACTION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RATS; RATS, INBRED LEW; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 84861138496     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103698     Document Type: Article

References (60)

1. Getts, D. R., S. Shankar, E. M. Chastain, A. Martin, M. T. Getts, K. Wood, and S. D. Miller. 2011. Current landscape for T-cell targeting in autoimmunity and transplantation. Immunotherapy 3: 853-870.
2. Starzl, T. E., S. Todo, J. Fung, A. J. Demetris, R. Venkataramman, and A. Jain. 1989. FK 506 for liver, kidney, and pancreas transplantation. Lancet 2: 1000-1004. (Pubitemid 19257914)
3. Goldstein, D. R. 2011. T cell costimulation blockade and organ transplantation: a change of philosophy for transplant immunologists? J. Immunol. 186: 2691-2692.
4. Adams, A. B., C. P. Larsen, T. C. Pearson, and K. A. Newell. 2002. The role of TNF receptor and TNF superfamily molecules in organ transplantation. Am. J. Transplant. 2: 12-18. (Pubitemid 36306802)
5. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68. (Pubitemid 40563164)
6. del Rio, M. L., L. Buhler, C. Gibbons, J. Tian, and J. I. Rodriguez-Barbosa. 2008. PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transpl. Int. 21: 1015-1028.
7. del Rio, M. L., C. L. Lucas, L. Buhler, G. Rayat, and J. I. Rodriguez-Barbosa. 2010. HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation. J. Leukoc. Biol. 87: 223-235.
8. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-620. (Pubitemid 37328664)
9. Hsu, H., I. Solovyev, A. Colombero, R. Elliott, M. Kelley, and W. J. Boyle. 1997. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J. Biol. Chem. 272: 13471-13474. (Pubitemid 27224772)
10. Steinberg, M. W., O. Turovskaya, R. B. Shaikh, G. Kim, D. F. McCole, K. Pfeffer, K. M. Murphy, C. F. Ware, and M. Kronenberg. 2008. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J. Exp. Med. 205: 1463-1476. (Pubitemid 351831500)
11. Gavrieli, M., N. Watanabe, S. K. Loftin, T. L. Murphy, and K. M. Murphy. 2003. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem. Biophys. Res. Commun. 312: 1236-1243. (Pubitemid 37490949)
12. Vendel, A. C., J. Calemine-Fenaux, A. Izrael-Tomasevic, V. Chauhan, D. Arnott, and D. L. Eaton. 2009. B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK. J. Immunol. 182: 1509-1517.
13. Watanabe, N., M. Gavrieli, J. R. Sedy, J. Yang, F. Fallarino, S. K. Loftin, M. A. Hurchla, N. Zimmerman, J. Sim, X. Zang, et al. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4: 670-679. (Pubitemid 36874444)
14. Hurchla, M. A., J. R. Sedy, M. Gavrieli, C. G. Drake, T. L. Murphy, and K. M. Murphy. 2005. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly induced in anergic CD4+ T cells. J. Immunol. 174: 3377-3385. (Pubitemid 40354042)
15. Compaan, D. M., L. C. Gonzalez, I. Tom, K. M. Loyet, D. Eaton, and S. G. Hymowitz. 2005. Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J. Biol. Chem. 280: 39553-39561. (Pubitemid 41713914)
16. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501. (Pubitemid 32201945)
17. Cai, G., A. Anumanthan, J. A. Brown, E. A. Greenfield, B. Zhu, and G. J. Freeman. 2008. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 9: 176-185.
18. Gonzalez, L. C., K. M. Loyet, J. Calemine-Fenaux, V. Chauhan, B. Wranik, W. Ouyang, and D. L. Eaton. 2005. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. USA 102: 1116-1121. (Pubitemid 40170735)
19. Cheung, T. C., I. R. Humphreys, K. G. Potter, P. S. Norris, H. M. Shumway, B. R. Tran, G. Patterson, R. Jean-Jacques, M. Yoon, P. G. Spear, et al. 2005. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc. Natl. Acad. Sci. USA 102: 13218-13223. (Pubitemid 41325004)
20. Sedy, J. R., M. Gavrieli, K. G. Potter, M. A. Hurchla, R. C. Lindsley, K. Hildner, S. Scheu, K. Pfeffer, C. F. Ware, T. L. Murphy, and K. M. Murphy. 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6: 90-98. (Pubitemid 40136700)
21. Mauri, D. N., R. Ebner, R. I. Montgomery, K. D. Kochel, T. C. Cheung, G. L. Yu, S. Ruben, M. Murphy, R. J. Eisenberg, G. H. Cohen, et al. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8: 21-30. (Pubitemid 28097820)
22. Cheung, T. C., M. W. Steinberg, L. M. Oborne, M. G. Macauley, S. Fukuyama, H. Sanjo, C. D'Souza, P. S. Norris, K. Pfeffer, K. M. Murphy, et al. 2009. Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc. Natl. Acad. Sci. USA 106: 6244-6249.
23. Ware, C. F., and J. R. Sedý. 2011. TNF superfamily networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14). Curr. Opin. Immunol. 23: 627-631.
24. del Rio, M. L., J. Kaye, and J. I. Rodriguez-Barbosa. 2010. Detection of protein on BTLAlow cells and in vivo y-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants. Immunobiology 215: 570-578.
25. Ito, T., K. Iwamoto, I. Tsuji, H. Tsubouchi, H. Omae, T. Sato, H. Ohba, T. Kurokawa, Y. Taniyama, and Y. Shintani. 2011. Trimerization of murine TNF ligand family member LIGHT increases the cytotoxic activity against the FM3A mammary carcinoma cell line. Appl. Microbiol. Biotechnol. 90: 1691-1699.
26. Katsel, P. L., and R. J. Greenstein. 2000. Eukaryotic gene transfer with liposomes: effect of differences in lipid structure. Biotechnol. Annu. Rev. 5: 197-220. (Pubitemid 41081547)
27. del Rio, M. L., G. Penuelas-Rivas, R. Dominguez-Perles, P. Ramirez, P. Parrilla, and J. I. Rodriguez-Barbosa. 2005. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation. Eur. J. Immunol. 35: 3545-3560. (Pubitemid 43025535)
28. del Rio, M. L., J. I. Rodriguez-Barbosa, J. Bölter, M. Ballmaier, O. Dittrich-Breiholz, M. Kracht, S. Jung, and R. Förster. 2008. CX3CR1+ c-kit+ bone marrow cells give rise to CD103+ and CD1032 dendritic cells with distinct functional properties. J. Immunol. 181: 6178-6188.
29. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78. (Pubitemid 37324571)
30. Vikingsson, A., K. Pederson, and D. Muller. 1994. Enumeration of IFN-gamma producing lymphocytes by flow cytometry and correlation with quantitative measurement of IFN-gamma. J. Immunol. Methods 173: 219-228.
31. Oehen, S., K. Brduscha-Riem, A. Oxenius, and B. Odermatt. 1997. A simple method for evaluating the rejection of grafted spleen cells by flow cytometry and tracing adoptively transferred cells by light microscopy. J. Immunol. Methods 207: 33-42. (Pubitemid 27400470)
32. Brehm, M. A., K. A. Daniels, J. R. Ortaldo, and R. M. Welsh. 2005. Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo. J. Immunol. 174: 6663-6671. (Pubitemid 40705627)
33. Hale, G., M. Clark, and H. Waldmann. 1985. Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes. J. Immunol. 134: 3056-3061. (Pubitemid 16238270)
34. Watts, T. H., and J. L. Gommerman. 2005. The LIGHT and DARC sides of herpesvirus entry mediator. Proc. Natl. Acad. Sci. USA 102: 13365-13366. (Pubitemid 41420852)
35. Nelson, C. A., M. D. Fremont, J. R. Sedy, P. S. Norris, C. F. Ware, K. M. Murphy, and D. H. Fremont. 2008. Structural determinants of herpesvirus entry mediator recognition by murine B and T lymphocyte attenuator. J. Immunol. 180: 940-947.
36. Morel, Y., J. M. Schiano de Colella, J. Harrop, K. C. Deen, S. D. Holmes, T. A. Wattam, S. S. Khandekar, A. Truneh, R. W. Sweet, J. A. Gastaut, et al. 2000. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J. Immunol. 165: 4397-4404.
37. Murphy, T. L., and K. M. Murphy. 2010. Slow down and survive: enigmatic immunoregulation by BTLA and HVEM. Annu. Rev. Immunol. 28: 389-411.
38. Tschetter, J. R., E. Mozes, and G. M. Shearer. 2000. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J. Immunol. 165: 5987-5994.
39. Pulaiev, R. A., I. A. Puliaeva, A. E. Ryan, and C. S. Via. 2005. The parent-into-F1 model of graft-vs-host disease as a model of in vivo T cell function and immunomodulation. Curr. Med. Chem. Immunol. Endocr. Metab. Agents 5: 575-583. (Pubitemid 41670983)
40. Ferrara, J. L., and P. Reddy. 2006. Pathophysiology of graft-versus-host disease. Semin. Hematol. 43: 3-10. (Pubitemid 43063330)
41. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9: 271-285.
42. Hehlgans, T., and K. Pfeffer. 2005. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115: 1-20. (Pubitemid 40598088)
43. Xu, Y., A. S. Flies, D. B. Flies, G. Zhu, S. Anand, S. J. Flies, H. Xu, R. A. Anders, W. W. Hancock, L. Chen, and K. Tamada. 2007. Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graftversus-host disease. Blood 109: 4097-4104. (Pubitemid 46641766)
44. Albring, J. C., M. M. Sandau, A. S. Rapaport, B. T. Edelson, A. Satpathy, M. Mashayekhi, S. K. Lathrop, C. S. Hsieh, M. Stelljes, M. Colonna, et al. 2010. Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression. J. Exp. Med. 207: 2551-2559.
45. Sakoda, Y., J. J. Park, Y. Zhao, A. Kuramasu, D. Geng, Y. Liu, E. Davila, and K. Tamada. 2011. Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway. Blood 117: 2506-2514.
46. Ye, Q., C. C. Fraser,W. Gao, L.Wang, S. J. Busfield, C. Wang, Y. Qiu, A. J. Coyle, J. C. Gutierrez-Ramos, and W. W. Hancock. 2002. Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J. Exp. Med. 195: 795-800. (Pubitemid 34259724)
47. Scheu, S., J. Alferink, T. Pötzel, W. Barchet, U. Kalinke, and K. Pfeffer. 2002. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J. Exp. Med. 195: 1613-1624. (Pubitemid 34666074)
48. Wan, X., J. Zhang, H. Luo, G. Shi, E. Kapnik, S. Kim, P. Kanakaraj, and J. Wu. 2002. A TNF family member LIGHT transduces costimulatory signals into human T cells. J. Immunol. 169: 6813-6821. (Pubitemid 36899266)
49. Tamada, K., J. Ni, G. Zhu, M. Fiscella, B. Teng, J. M. van Deursen, and L. Chen. 2002. Cutting edge: selective impairment of CD8+ T cell function in mice lacking the TNF superfamily member LIGHT. J. Immunol. 168: 4832-4835. (Pubitemid 34495943)
50. Shi, G., H. Luo, X. Wan, T. W. Salcedo, J. Zhang, and J. Wu. 2002. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 100: 3279-3286. (Pubitemid 35217078)
51. Cheung, T. C., L. M. Oborne, M. W. Steinberg, M. G. Macauley, S. Fukuyama, H. Sanjo, C. D'Souza, P. S. Norris, K. Pfeffer, K. M. Murphy, et al. 2009. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment. J. Immunol. 183: 7286-7296.
52. Hurchla, M. A., J. R. Sedy, and K. M. Murphy. 2007. Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation. J. Immunol. 178: 6073-6082. (Pubitemid 46717387)
53. Sykes, M., and T. R. Spitzer. 2002. Non-myeloblative induction of mixed hematopoietic chimerism: application to transplantation tolerance and hematologic malignancies in experimental and clinical studies. Cancer Treat. Res. 110: 79-99.
54. Hakim, F., D. H. Fowler, G. M. Shearer, and R. E. Gress. 2001. Animal models of acute and chronic graft-versus-host disease. Curr. Protoc. Immunol. Chapter 4: Unit 4.3.
55. Sprent, J., and C. D. Surh. 2011. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat. Immunol. 12: 478-484.
56. Hickman, S. P., and L. A. Turka. 2005. Homeostatic T cell proliferation as a barrier to T cell tolerance. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360: 1713-1721. (Pubitemid 43997820)
57. Wu, Z., S. J. Bensinger, J. Zhang, C. Chen, X. Yuan, X. Huang, J. F. Markmann, A. Kassaee, B. R. Rosengard, W. W. Hancock, et al. 2004. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 10: 87-92. (Pubitemid 38524703)
58. Schroeder, M. A., and J. F. DiPersio. 2011. Mouse models of graft-versus-host disease: advances and limitations. Dis. Model Mech. 4: 318-333.
59. Gleichmann, E., and H. Gleichmann. 1985. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J. Invest. Dermatol. 85: 115s-120s. (Pubitemid 16235464)
60. Ferrara, J. L., J. E. Levine, P. Reddy, and E. Holler. 2009. Graft-versus-host disease. Lancet 373: 1550-1561.